END-STAGE KIDNEY DISEASE (ESKD)
Clinical trials for END-STAGE KIDNEY DISEASE (ESKD) explained in plain language.
Never miss a new study
Get alerted when new END-STAGE KIDNEY DISEASE (ESKD) trials appear
Sign up with your email to follow new studies for END-STAGE KIDNEY DISEASE (ESKD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a meal during dialysis boost energy without hurting treatment?
Disease control CompletedThis study tests whether eating a special kidney-friendly meal during hemodialysis affects how well the treatment works and how tired patients feel. Adults on maintenance dialysis will receive the meal during one period and no food during another, acting as their own control. Res…
Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)
Phase: NA • Sponsor: Mersin University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug aims to tame parathyroid glands in dialysis patients
Disease control CompletedThis study tested a drug called PLS240 in 362 adults with end-stage kidney disease on dialysis who also have overactive parathyroid glands (secondary hyperparathyroidism). Participants received either PLS240 or a placebo during dialysis three times a week for 27 weeks, followed b…
Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Jun 26, 2026 14:38 UTC